The Dividend Registry.
HIK · FTSE 250

Hikma Pharmaceuticals

Hikma Pharmaceuticals's latest dividend of US$0.38 per share went ex-dividend on 13 Aug 2026 and is due to be paid on 17 Sep 2026. Hikma Pharmaceuticals usually pays two dividends a year, in April and September. Every date below is taken from the company's own regulatory filings.

Data updated

Hikma Pharmaceuticals dividends by year

What Hikma Pharmaceuticals paid in each of its own financial years, on the basis the company reports. A company’s year and the dates its dividends reach shareholders do not always line up, so a dividend can sit under a different year here than on the payment-dates view. Hikma Pharmaceuticals’s financial year ends 31 Dec.

Total dividend per share for each financial year, as stated by the company, since 2015. The outlined bar is the year in progress: the payments declared so far, not a full-year figure. Hover a bar for its value; the table below is the full record, each row linked to its source filing.
Year endedTotalChangeInterimFinalSource
31 Dec 2026In progressUS$0.38 so far———Payments above
31 Dec 2025US$0.84+5.0%US$0.36US$0.48Filing ↗
31 Dec 2024US$0.80+11.1%US$0.32US$0.48Filing ↗
31 Dec 2023US$0.72+28.6%US$0.25US$0.47Filing ↗
31 Dec 2022US$0.56+3.7%US$0.19US$0.37Filing ↗
31 Dec 2021US$0.54+8.0%US$0.18US$0.36Filing ↗
31 Dec 2020US$0.50+13.6%US$0.16US$0.34Filing ↗
31 Dec 2019US$0.44+15.8%US$0.14US$0.30Filing ↗
31 Dec 2018US$0.38+11.8%US$0.12US$0.26Filing ↗
31 Dec 2017US$0.34+3.0%US$0.11US$0.23Filing ↗
31 Dec 2016US$0.33+3.1%US$0.11US$0.22Filing ↗
31 Dec 2015US$0.32—US$0.11US$0.21Filing ↗

Each year’s total is the figure Hikma Pharmaceuticals itself published, linked to the announcement it appeared in, and every payment behind it has been checked against that total. Hikma Pharmaceuticals’s financial year ends 31 Dec.

Every annual total above is the figure Hikma Pharmaceuticals published in its own results announcement, filed under UK listing rules, and links back to it. This is general information, not investment advice — always confirm against the company’s announcement before acting. Figures are shown in the currency the company declared.